scholarly article | Q13442814 |
P50 | author | Guido Kobbe | Q94590887 |
Arnold Ganser | Q99412936 | ||
Jürgen Finke | Q114426803 | ||
Silke Heidenreich | Q114426811 | ||
Arne Brecht | Q114426819 | ||
Linda Koster | Q114426824 | ||
Per Ljungman | Q52717443 | ||
Liisa Volin | Q53381572 | ||
Ibrahim Yakoub-Agha | Q58191171 | ||
Thomas Luft | Q59562402 | ||
Uwe Platzbecker | Q71792160 | ||
Liesbeth De Wreede | Q82675560 | ||
Nicolaus Kröger | Q86950236 | ||
Johannes Schetelig | Q87777753 | ||
Matthias Stelljes | Q87844970 | ||
Dietger Niederwieser | Q88402151 | ||
Michel van Gelder | Q88901058 | ||
Dietrich W Beelen | Q89402080 | ||
Johan Maertens | Q89490552 | ||
P2093 | author name string | Gerard Socié | |
Marie Robin | |||
Arnon Nagler | |||
Antonin Vitek | |||
G J Mufti | |||
P2860 | cites work | Allogeneic stem cell transplantation for elderly patients with myelodysplastic syndrome | Q27028159 |
Secondary solid cancer screening following hematopoietic cell transplantation | Q28088369 | ||
National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Research Methodology and Study Design Working Group Report | Q30245682 | ||
Comparison of allogeneic stem cell transplantation and non-transplant approaches in elderly patients with advanced myelodysplastic syndrome: optimal statistical approaches and a critical appraisal of clinical results using non-randomized data | Q30675919 | ||
Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation | Q33615619 | ||
Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation | Q33710708 | ||
Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome | Q33813439 | ||
Relapse and late mortality in 5-year survivors of myeloablative allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in first chronic phase | Q33813443 | ||
Geriatric assessment to predict survival in older allogeneic hematopoietic cell transplantation recipients. | Q33978945 | ||
Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation | Q34260505 | ||
Reduced mortality after allogeneic hematopoietic-cell transplantation | Q34472861 | ||
Long-term survival and late deaths after allogeneic hematopoietic cell transplantation | Q35023409 | ||
Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study | Q36141716 | ||
Analysing population-based cancer survival - settling the controversies | Q36212210 | ||
Long-term survival of patients with CLL after allogeneic transplantation: a report from the European Society for Blood and Marrow Transplantation. | Q36219840 | ||
Suggestions on the use of statistical methodologies in studies of the European Group for Blood and Marrow Transplantation | Q38086718 | ||
National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: Developing Recommendations to Improve Survivorship and Long-Term Outcomes | Q38374821 | ||
Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel | Q39092515 | ||
Allogeneic Stem Cell Transplantation for Patients Age ≥ 70 Years with Myelodysplastic Syndrome: A Retrospective Study of the MDS Subcommittee of the Chronic Malignancies Working Party of the EBMT. | Q39308114 | ||
Allogeneic Hematopoietic Stem Cell Transplantation Is Underutilized in Older Patients with Myelodysplastic Syndromes | Q40276791 | ||
Cytogenetics and comorbidity predict outcomes in older myelodysplastic syndrome patients after allogeneic stem cell transplantation using reduced intensity conditioning | Q40282393 | ||
Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelo | Q44295238 | ||
Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States | Q46389618 | ||
How I monitor long-term and late effects after blood or marrow transplantation | Q47571887 | ||
Cancer Survivorship Care in Advanced Primary Care Practices: A Qualitative Study of Challenges and Opportunities | Q47874534 | ||
Prevalence of Prior Cancer Among Persons Newly Diagnosed With Cancer: An Initial Report From the Surveillance, Epidemiology, and End Results Program | Q49722439 | ||
The mstate package for estimation and prediction in non- and semi-parametric multi-state and competing risks models. | Q51714177 | ||
Quantification of the completeness of follow-up. | Q52938972 | ||
Characteristics of Late Fatal Infections after Allogeneic Hematopoietic Cell Transplant | Q57052529 | ||
Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry | Q77941016 | ||
Allogeneic hematopoietic stem-cell transplantation for patients 50 years or older with myelodysplastic syndromes or secondary acute myeloid leukemia | Q82236404 | ||
Relative survival analysis in R | Q82697345 | ||
Risk and timing of cardiovascular death among patients with myelodysplastic syndromes | Q89777441 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | leukemia | Q29496 |
acute myeloid leukemia | Q264118 | ||
P1104 | number of pages | 10 | |
P304 | page(s) | 686-695 | |
P577 | publication date | 2018-12-20 | |
P1433 | published in | Leukemia | Q6534498 |
P1476 | title | Late treatment-related mortality versus competing causes of death after allogeneic transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia | |
P478 | volume | 33 |
Q64116751 | Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis | cites work | P2860 |
Search more.